Rare diseases research

Orphan indications, n=1 genomic medicine, gene therapy for small populations.

Rare diseases are where the most novel gene and cell therapies emerge first. Relaylit tracks Europe PMC (strong coverage of rare-disease journals), PubMed, and preprints so clinicians caring for orphan populations don't miss the one paper that matters.

Example brief

"Gene therapy for lysosomal storage disorders and other inborn errors of metabolism, last 18 months."

Paste this into your Relaylit profile and tweak. First digest arrives within hours.

Where Relaylit searches for this topic

PubMed

35M+ biomedical citations from MEDLINE, life-science journals, and online books.

About PubMed →

Europe PMC

42M+ life science citations, including preprints and full-text open-access papers.

About Europe PMC →

OpenAlex

Free, open replacement for Microsoft Academic Graph with 250M+ works across every discipline.

About OpenAlex →

How Relaylit tracks rare diseases research

1. Describe it once

Paste a plain-language brief for rare diseases research. No boolean operators, no saved-search syntax.

2. We search 3 databases

Relaylit queries PubMed, Europe PMC and OpenAlex on the live APIs, deduplicates the results, and ranks each paper against your brief.

3. Read the digest

A focused, ranked email lands weekly, biweekly, or monthly — the strongest rare diseases research work, not a raw feed.

Frequently asked questions

Which research databases does Relaylit search for rare diseases research?

Relaylit searches PubMed, Europe PMC and OpenAlex for rare diseases research. Every result is pulled from the live APIs each time your digest is generated, so new work reaches you within hours of being indexed.

How often will I get rare diseases research updates?

You choose the cadence — weekly, biweekly, or monthly. Each digest ranks every new match against your brief and emails you a focused, ranked selection instead of a raw feed.

Can I customise what counts as relevant?

Yes. You write a plain-language brief — for example: "Gene therapy for lysosomal storage disorders and other inborn errors of metabolism, last 18 months." — and Relaylit ranks every result against it. Tighten or broaden the brief any time.

Is tracking rare diseases research free?

Relaylit is free for up to two topics, so you can track rare diseases research at no cost. Paid plans add more topics and higher frequency.

Ready to track this?

Your first rare diseases research digest lands this week.

Start free